1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Physical Therapy Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Physical Therapy Market, by Application
8.1.1. Orthopedic Physical Therapy
8.1.1.1. Market Revenue and Forecast
8.1.2. Geriatric Physical Therapy
8.1.2.1. Market Revenue and Forecast
8.1.3. Neurological Physical Therapy
8.1.3.1. Market Revenue and Forecast
8.1.4. Cardiopulmonary and Pulmonary Physical Therapy
8.1.4.1. Market Revenue and Forecast
8.1.5. Others
8.1.5.1. Market Revenue and Forecast
9.1. Physical Therapy Market, by Age Group
9.1.1. Pediatrics
9.1.1.1. Market Revenue and Forecast
9.1.2. Adults
9.1.2.1. Market Revenue and Forecast
9.1.3. Elderly
9.1.3.1. Market Revenue and Forecast
10.1. Physical Therapy Market, by End-User
10.1.1. Hospitals
10.1.1.1. Market Revenue and Forecast
10.1.2. Private Practices
10.1.2.1. Market Revenue and Forecast
10.1.3. Outpatient Clinics
10.1.3.1. Market Revenue and Forecast
10.1.4. Sports and Fitness Facility Centers
10.1.4.1. Market Revenue and Forecast
10.1.5. Others
10.1.5.1. Market Revenue and Forecast
11.1. Physical Therapy Market, by Treatment Procedure
11.1.1. Equipment
11.1.1.1. Market Revenue and Forecast
11.1.2. Therapies
11.1.2.1. Market Revenue and Forecast
11.1.3. Products
12.1. North America
12.1.1. Market Revenue and Forecast, by Application
12.1.2. Market Revenue and Forecast, by Age Group
12.1.3. Market Revenue and Forecast, by End-User
12.1.4. Market Revenue and Forecast, by Treatment Procedure
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Application
12.1.5.2. Market Revenue and Forecast, by Age Group
12.1.5.3. Market Revenue and Forecast, by End-User
12.1.5.4. Market Revenue and Forecast, by Treatment Procedure
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Application
12.1.6.2. Market Revenue and Forecast, by Age Group
12.1.6.3. Market Revenue and Forecast, by End-User
12.1.6.4. Market Revenue and Forecast, by Treatment Procedure
12.2. Europe
12.2.1. Market Revenue and Forecast, by Application
12.2.2. Market Revenue and Forecast, by Age Group
12.2.3. Market Revenue and Forecast, by End-User
12.2.4. Market Revenue and Forecast, by Treatment Procedure
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Application
12.2.5.2. Market Revenue and Forecast, by Age Group
12.2.5.3. Market Revenue and Forecast, by End-User
12.2.5.4. Market Revenue and Forecast, by Treatment Procedure
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Application
12.2.6.2. Market Revenue and Forecast, by Age Group
12.2.6.3. Market Revenue and Forecast, by End-User
12.2.6.4. Market Revenue and Forecast, by Treatment Procedure
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Application
12.2.7.2. Market Revenue and Forecast, by Age Group
12.2.7.3. Market Revenue and Forecast, by End-User
12.2.7.4. Market Revenue and Forecast, by Treatment Procedure
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Application
12.2.8.2. Market Revenue and Forecast, by Age Group
12.2.8.3. Market Revenue and Forecast, by End-User
12.2.8.4. Market Revenue and Forecast, by Treatment Procedure
12.3. APAC
12.3.1. Market Revenue and Forecast, by Application
12.3.2. Market Revenue and Forecast, by Age Group
12.3.3. Market Revenue and Forecast, by End-User
12.3.4. Market Revenue and Forecast, by Treatment Procedure
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Application
12.3.5.2. Market Revenue and Forecast, by Age Group
12.3.5.3. Market Revenue and Forecast, by End-User
12.3.5.4. Market Revenue and Forecast, by Treatment Procedure
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Application
12.3.6.2. Market Revenue and Forecast, by Age Group
12.3.6.3. Market Revenue and Forecast, by End-User
12.3.6.4. Market Revenue and Forecast, by Treatment Procedure
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Application
12.3.7.2. Market Revenue and Forecast, by Age Group
12.3.7.3. Market Revenue and Forecast, by End-User
12.3.7.4. Market Revenue and Forecast, by Treatment Procedure
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Application
12.3.8.2. Market Revenue and Forecast, by Age Group
12.3.8.3. Market Revenue and Forecast, by End-User
12.3.8.4. Market Revenue and Forecast, by Treatment Procedure
12.4. MEA
12.4.1. Market Revenue and Forecast, by Application
12.4.2. Market Revenue and Forecast, by Age Group
12.4.3. Market Revenue and Forecast, by End-User
12.4.4. Market Revenue and Forecast, by Treatment Procedure
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Application
12.4.5.2. Market Revenue and Forecast, by Age Group
12.4.5.3. Market Revenue and Forecast, by End-User
12.4.5.4. Market Revenue and Forecast, by Treatment Procedure
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Application
12.4.6.2. Market Revenue and Forecast, by Age Group
12.4.6.3. Market Revenue and Forecast, by End-User
12.4.6.4. Market Revenue and Forecast, by Treatment Procedure
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Application
12.4.7.2. Market Revenue and Forecast, by Age Group
12.4.7.3. Market Revenue and Forecast, by End-User
12.4.7.4. Market Revenue and Forecast, by Treatment Procedure
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Application
12.4.8.2. Market Revenue and Forecast, by Age Group
12.4.8.3. Market Revenue and Forecast, by End-User
12.4.8.4. Market Revenue and Forecast, by Treatment Procedure
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Application
12.5.2. Market Revenue and Forecast, by Age Group
12.5.3. Market Revenue and Forecast, by End-User
12.5.4. Market Revenue and Forecast, by Treatment Procedure
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Application
12.5.5.2. Market Revenue and Forecast, by Age Group
12.5.5.3. Market Revenue and Forecast, by End-User
12.5.5.4. Market Revenue and Forecast, by Treatment Procedure
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Application
12.5.6.2. Market Revenue and Forecast, by Age Group
12.5.6.3. Market Revenue and Forecast, by End-User
12.5.6.4. Market Revenue and Forecast, by Treatment Procedure
13.1. AmeriCare Physical Therapy (U.S.)
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Rehab Alternatives PLLC (U.S.)
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. PIVOT Physical Therapy (U.S.)
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. ProHealth Limited (Hong Kong)
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Abb BTL (India)
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. DJO LLC (U.S.)
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Performance Health (U.S.)
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Athletico Physical Therapy (U.S.)
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Abb Geisinger Health (U.S.)ott
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Select Medical Corporation (U.S.)
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client